argenx SE | ARGX - Ebit

Stock Price
693.20
Daily Change
-1.00 -0.14%
Monthly
-2.45%
Yearly
37.43%
Q2 Forecast
678.23

argenx SE reported $394M in EBIT for its fiscal quarter ending in March of 2026.





Ebit Change Date
AstraZeneca USD 7.11B 4.14B Mar/2026
Genmab DKK 260M 199M Dec/2025
GlaxoSmithKline GBP 2.29B 856M Mar/2026
GRIFOLS EUR 249M 103.11M Mar/2026
Hikma Pharmaceutical USD 348M 31M Dec/2025
Lakefront Biotherapeutics EUR -63.7M 844.26M Mar/2026
Qiagen NV USD 121.88M 19.18M Dec/2025
UCB EUR 1.29B 571M Dec/2025